• Latest Posts

Hoag’s high hopes for new drug with Alzheimer’s disease trial

Liquid-interface assisted SERS could lead to earlier detection of Alzheimer’s

Alzinova announces new positive safety review for Alzheimer’s study

Proxidrugs: a new tool to fight pathogens?

Biogen, citing insurance challenges, shutters one of its Aduhelm studies

Boost for dementia gene-based therapies

Sponsored by 22 Sep 2021

Discovering New Therapeutic Targets for Alzheimer’s Disease

AC Immune’s Mixed Phase II Results Buoy Alzheimer’s Research

Danish Dementia Startup Launches Amid Maturing Nordic Biotech Scene

Scotland’s Top 10 Biotech Companies to Watch Out For

FDA Approval of Biogen’s Drug Boosts European Alzheimer’s Space

Late-Stage Success Raises Hopes to Tackle Alzheimer’s via Inflammation